172 related articles for article (PubMed ID: 7472911)
1. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG.
Biller JA; Katz AJ; Flores AF; Buie TM; Gorbach SL
J Pediatr Gastroenterol Nutr; 1995 Aug; 21(2):224-6. PubMed ID: 7472911
[No Abstract] [Full Text] [Related]
2. [Pseudo-membranous colitis].
Watanabe K; Tanaka K
Nihon Rinsho; 2003 Feb; 61 Suppl 2():475-80. PubMed ID: 12722265
[No Abstract] [Full Text] [Related]
3. Evaluation of commercially available rapid assays: a manufacturer's perspective.
Hart I
J Clin Microbiol; 2001 Dec; 39(12):4601. PubMed ID: 11797611
[No Abstract] [Full Text] [Related]
4. Glutamate dehydrogenase for laboratory diagnosis of Clostridium difficile infection.
Goldenberg SD; Cliff PR; French GL
J Clin Microbiol; 2010 Aug; 48(8):3050-1; author reply 3051. PubMed ID: 20668302
[No Abstract] [Full Text] [Related]
5. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic tests: Clostridium difficile].
Okada J
Nihon Rinsho; 2005 Jul; 63 Suppl 7():210-3. PubMed ID: 16111229
[No Abstract] [Full Text] [Related]
7. [Influence of selected Lactobacillus sp. on Clostridium difficile strains with different toxigenicity profile].
Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
Med Dosw Mikrobiol; 2006; 58(2):127-33. PubMed ID: 17133906
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing of Clostridium difficile colitis.
Wiwanitkit V
South Med J; 2010 Mar; 103(3):278-9. PubMed ID: 20134370
[No Abstract] [Full Text] [Related]
9. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens.
Alcalá L; Sánchez-Cambronero L; Catalán MP; Sánchez-Somolinos M; Peláez MT; Marín M; Bouza E
J Clin Microbiol; 2008 Nov; 46(11):3833-5. PubMed ID: 18784313
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.
Lozniewski A; Rabaud C; Dotto E; Weber M; Mory F
J Clin Microbiol; 2001 May; 39(5):1996-8. PubMed ID: 11326033
[TBL] [Abstract][Full Text] [Related]
11. [Six years evaluation of Clostridium difficile associated diarrhea].
Ercis S; Ergin A; Hasçelik G
Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic possibilities of probiotics in antibiotic-related diarrhea].
Krämer S; Bischoff SC
MMW Fortschr Med; 2006 Aug; 148(35-36):28-30. PubMed ID: 16995359
[TBL] [Abstract][Full Text] [Related]
13. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile infection of the gut.
Dodson AP; Borriello SP
J Clin Pathol; 1996 Jul; 49(7):529-32. PubMed ID: 8813947
[No Abstract] [Full Text] [Related]
15. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B.
Cook L; Rees WD; Wong MQ; Peters H; Levings MK; Steiner TS
Gastroenterology; 2021 May; 160(6):2155-2158.e4. PubMed ID: 33444574
[No Abstract] [Full Text] [Related]
16. [Clostridium difficile-induced enterocolitis: pathogenesis, clinical course, epidemiology and laboratory diagnosis].
Meyer-Kawohl R; Bockemühl J
Immun Infekt; 1986 Apr; 14(2):63-7. PubMed ID: 3519433
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
Novak-Weekley SM; Hollingsworth MH
Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated colitis in north India.
Ayyagari A; Sharma P; Venkateswarlu ; Mehta S; Agarwal KC
J Diarrhoeal Dis Res; 1986 Sep; 4(3):157-60. PubMed ID: 3584906
[No Abstract] [Full Text] [Related]
19. Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.
Napierala M; Munson E; Skonieczny P; Rodriguez S; Riederer N; Land G; Luzinski M; Block D; Hryciuk JE
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):534-8. PubMed ID: 23731555
[TBL] [Abstract][Full Text] [Related]
20. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.
Buts JP; Corthier G; Delmee M
J Pediatr Gastroenterol Nutr; 1993 May; 16(4):419-25. PubMed ID: 8315551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
